According to Fortune Business Insights, the global gene synthesis market size was valued at USD 2.81 billion in 2025. The market is projected to grow from USD 3.27 billion in 2026 to USD 10.99 billion by 2034, exhibiting a CAGR of 16.36% during the forecast period. The increasing adoption of synthetic biology, growing investments in genomic research, rising demand for precision medicine, and advancements in genetic engineering technologies are driving market expansion. North America dominated the global market with a 42% revenue share in 2025.
Gene Synthesis Market Overview
Gene synthesis refers to the artificial creation of DNA sequences using chemical or enzymatic methods without requiring an existing DNA template. This technology enables researchers to design and manufacture customized genetic sequences for applications across biotechnology, pharmaceuticals, healthcare, agriculture, and industrial research.
The growing importance of synthetic biology and genetic engineering has increased the demand for customized DNA sequences. Pharmaceutical companies, biotechnology organizations, academic institutions, and research laboratories are increasingly adopting gene synthesis technologies to accelerate drug discovery, develop innovative therapies, and improve molecular diagnostics.
Furthermore, advancements in DNA synthesis platforms, automated laboratory systems, and artificial intelligence-based sequence optimization are improving synthesis accuracy, reducing production timelines, and supporting large-scale genetic research. These developments are creating new opportunities for companies operating in the global gene synthesis industry.
Key Market Trends Driving the Gene Synthesis Industry
1. Increasing Adoption of Synthetic Biology
Synthetic biology is emerging as a significant trend in the gene synthesis market. Researchers are increasingly using synthetic DNA to develop engineered biological systems, improve microbial production processes, and create innovative solutions for pharmaceutical and agricultural applications.
The growing adoption of synthetic biology is encouraging biotechnology companies to invest in advanced gene synthesis technologies that support complex DNA construction and genetic modification.
2. Integration of Artificial Intelligence in Gene Design
Artificial intelligence and machine learning are transforming gene synthesis workflows by improving DNA sequence design, codon optimization, and error detection. These technologies help researchers identify suitable genetic sequences and improve the accuracy of synthetic DNA production.
The integration of AI-powered bioinformatics platforms and automated laboratory systems is also helping manufacturers improve operational efficiency and reduce synthesis turnaround times.
3. Growing Demand for Personalized Medicine
The increasing focus on personalized medicine is supporting the adoption of gene synthesis technologies. Synthetic DNA sequences are widely utilized in genetic research, targeted therapies, molecular diagnostics, and the development of customized treatment approaches.
As healthcare organizations increasingly emphasize precision medicine, demand for reliable and customized gene synthesis services is expected to increase.
4. Expansion of CRISPR and Gene Editing Research
The growing adoption of CRISPR-based gene editing technologies is creating additional demand for synthetic DNA. Researchers use customized genetic sequences to support gene modification, functional genomics, and the development of innovative therapeutic approaches.
Increasing investments in genetic engineering and cell-based therapies are further supporting market expansion.
Request a Free Sample: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/gene-synthesis-market-117251
Gene Synthesis Market Growth Drivers
Rising Investments in Pharmaceutical and Biotechnology Research
Increasing investments in pharmaceutical research and biotechnology development are contributing significantly to market growth. Synthetic genes are essential for drug discovery, vaccine development, protein engineering, and the development of advanced biologics.
Pharmaceutical companies are increasingly adopting gene synthesis solutions to accelerate research processes and develop innovative therapeutic products.
Growing Demand for Advanced Molecular Diagnostics
The increasing use of molecular diagnostics and genomic testing is creating demand for high-quality synthetic DNA sequences. Gene synthesis technologies support diagnostic assay development, genetic testing, and molecular research by providing customized DNA materials.
Additionally, the growing prevalence of genetic research programs and the increasing focus on early disease detection are strengthening the adoption of these technologies.
Increasing Application in Vaccine and Cell Therapy Development
Gene synthesis plays an important role in developing advanced vaccines, gene therapies, and cell-based treatments. The growing adoption of mRNA technologies and CAR-T cell therapies is increasing the requirement for customized DNA constructs.
Biotechnology companies are investing in scalable gene synthesis platforms to support the development of innovative treatments and accelerate clinical research.
Market Restraints
High Costs Associated with Gene Synthesis Technologies
High production costs remain a significant challenge for the gene synthesis industry. Advanced synthesis equipment, specialized laboratory infrastructure, skilled professionals, and quality control procedures require substantial investments.
These expenses can limit the adoption of advanced synthesis technologies among smaller biotechnology companies and academic research institutions.
Biosecurity and Regulatory Concerns
The increasing use of synthetic DNA technologies has raised concerns regarding biological safety, ethical considerations, and potential misuse. Regulatory authorities are strengthening screening and compliance requirements to ensure the responsible use of synthetic genetic materials.
Gene synthesis providers must implement appropriate sequence screening, verification, and biosafety procedures, which can increase operational complexity and costs.
Gene Synthesis Market Segmentation Analysis
The global market is segmented by method, service, application, end-use, and region.
By Method
Based on method, the market is categorized into solid-phase synthesis, chip-based synthesis, and PCR-based enzyme synthesis.
The solid-phase synthesis segment dominated the market, accounting for approximately 46% of the global market share. Its dominance is attributed to its widespread use in oligonucleotide production, customized DNA sequence generation, and pharmaceutical research. The method offers high synthesis accuracy and scalability, making it suitable for various synthetic biology and molecular diagnostics applications.
The chip-based synthesis segment accounted for approximately 29% of the market. Its ability to generate multiple DNA sequences simultaneously makes it suitable for high-throughput genomic research, synthetic gene libraries, and CRISPR screening.
PCR-based enzyme synthesis accounted for approximately 25% of the market. Its flexibility and suitability for gene amplification, molecular cloning, and complex DNA assembly are supporting segment growth.
By Service
Based on service, the market includes custom gene synthesis and other related services.
The custom gene synthesis segment accounted for approximately 48% of the global market. Its leading position is supported by increasing demand for customized DNA constructs across pharmaceutical research, synthetic biology, and genetic engineering.
Service providers offer solutions such as sequence optimization, codon engineering, cloning, and vector integration to meet the requirements of biotechnology companies and research organizations.
By Application
Based on application, the market is segmented into therapeutics development, diagnostics, agricultural biotechnology, and other applications.
The therapeutics development segment dominated the market, accounting for approximately 39% of the global market share. Synthetic genes are extensively used in vaccine production, gene therapy, biologics development, and advanced drug discovery.
The diagnostics segment accounted for approximately 23% of the market. Increasing demand for molecular testing, genomic sequencing, infectious disease detection, and precision diagnostics is supporting its expansion.
Agricultural biotechnology is another important application area, where gene synthesis technologies support the development of genetically modified crops, improved plant characteristics, and advanced agricultural research.
Gene Synthesis Market Regional Outlook
North America
North America dominated the global gene synthesis market with a 42% revenue share in 2025. The region's leadership is attributed to its advanced biotechnology infrastructure, strong pharmaceutical research ecosystem, substantial investments in genomics, and increasing adoption of synthetic biology.
The U.S. represents a major contributor to regional growth due to the presence of biotechnology companies, pharmaceutical manufacturers, and academic research institutions. Increasing investments in CRISPR technologies, personalized medicine, and AI-powered gene design platforms are further supporting market expansion.
Europe
Europe accounted for approximately 27% of the global gene synthesis market. The region's growth is supported by increasing genomic research activities, advanced healthcare infrastructure, and strong pharmaceutical manufacturing capabilities.
Germany, the U.K., France, and Switzerland are important contributors to regional demand. Growing investments in personalized medicine, vaccine development, bioinformatics, and laboratory automation are creating favorable growth opportunities.
Asia-Pacific
Asia-Pacific represented approximately 24% of the global market and is emerging as an important region for gene synthesis technologies. Increasing biotechnology investments, expanding pharmaceutical manufacturing capabilities, and growing genomic research activities are supporting regional growth.
China, Japan, India, and South Korea are major contributors to the regional market. Government initiatives supporting biotechnology research and the growing adoption of precision medicine are further strengthening demand.
Japan is an important market due to its advanced biotechnology ecosystem and investments in regenerative medicine and genomics research. China is also witnessing increasing adoption of synthetic biology technologies, supported by expanding biotechnology infrastructure and government investments.
Rest of the World
The Rest of the World region accounted for approximately 7% of the global market. It includes Latin America, the Middle East, and Africa.
Increasing healthcare investments, growing awareness of genomic technologies, and expanding molecular diagnostics capabilities are supporting gradual market development. Investments in biotechnology infrastructure and agricultural research are expected to create additional opportunities.
Competitive Landscape of the Gene Synthesis Market
The global gene synthesis market is characterized by technological innovation, strategic investments, service expansion, and increasing competition among established biotechnology companies.
Leading market participants are focusing on automated DNA synthesis platforms, AI-driven sequence optimization, high-throughput manufacturing capabilities, and customized gene synthesis services to strengthen their competitive positions.
Some of the key companies operating in the global gene synthesis market include:
- GenScript
- Brooks Automation, Inc. (GENEWIZ)
- Boster Biological Technology
- Twist Bioscience
- ProteoGenix, Inc.
- Biomatik
- ProMab Biotechnologies, Inc.
- Thermo Fisher Scientific, Inc.
- Integrated DNA Technologies, Inc.
- OriGene Technologies, Inc.
According to the market report, Twist Bioscience holds approximately 17% market share, while Thermo Fisher Scientific, Inc. accounts for approximately 15%.
Read Report Insights: https://www.fortunebusinessinsights.com/gene-synthesis-market-117251
Future Opportunities in the Gene Synthesis Market
The future of the gene synthesis market is expected to be shaped by advancements in synthetic biology, precision medicine, gene editing, and automated DNA manufacturing technologies.
Increasing applications in cell therapy, immunotherapy, and mRNA vaccine development are expected to create significant opportunities for market participants. Pharmaceutical and biotechnology companies are increasingly utilizing synthetic genes to develop customized therapeutic solutions and improve drug discovery processes.
Furthermore, growing investments in agricultural biotechnology and industrial enzyme engineering are expanding the commercial applications of gene synthesis. The development of genetically modified crops, engineered microorganisms, and bio-based production systems is creating additional demand for customized DNA sequences.
Technological advancements in chip-based synthesis, AI-powered gene design, and automated quality control systems are also expected to improve production efficiency and support large-scale manufacturing.
Overall, increasing investments in biotechnology research and the growing adoption of genetic engineering technologies are expected to create substantial growth opportunities for the global gene synthesis market through 2034.
Frequently Asked Questions (FAQs)
1. How big is the Gene Synthesis Market?
Fortune Business Insights states that the global gene synthesis market size was valued at USD 2.81 billion in 2025. The market is projected to reach USD 10.99 billion by 2034.
2. What is the expected CAGR of the Gene Synthesis Market?
The global gene synthesis market is expected to grow at a CAGR of 16.36% during the forecast period of 2026-2034.
3. Which method segment dominates the Gene Synthesis Market?
Solid-phase synthesis dominates the market, accounting for approximately 46% of the global market share due to its high accuracy, scalability, and widespread application in customized DNA sequence generation.
4. Who are the key players in the Gene Synthesis Market?
Major companies operating in the global market include GenScript, Brooks Automation, Inc. (GENEWIZ), Boster Biological Technology, Twist Bioscience, ProteoGenix, Inc., and Biomatik.
5. What are the latest trends in the Gene Synthesis Market?
Major trends include increasing adoption of AI-driven gene design, automation in DNA synthesis, growing applications of synthetic biology, expansion of CRISPR-based research, and rising demand for customized genetic sequences in precision medicine, vaccine development, and cell therapy.
Explore Japan’s Market Opportunities - Latest - Gene Synthesis Market- Insights